These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34663374)

  • 21. Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic.
    Irvine MA; Kuo M; Buxton JA; Balshaw R; Otterstatter M; Macdougall L; Milloy MJ; Bharmal A; Henry B; Tyndall M; Coombs D; Gilbert M
    Addiction; 2019 Sep; 114(9):1602-1613. PubMed ID: 31166621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlates of opioid and benzodiazepine co-prescription among people living with HIV in British Columbia, Canada: A population-level cohort study.
    Parent S; Nolan S; Fairbairn N; Ye M; Wu A; Montaner J; Barrios R; Ti L;
    Int J Drug Policy; 2019 May; 67():52-57. PubMed ID: 30897373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intention to seek emergency medical services during community overdose events in British Columbia, Canada: a cross-sectional survey.
    Kievit B; Xavier JC; Ferguson M; Palis H; Moallef S; Slaunwhite A; Gillis T; Virk R; Buxton JA
    Subst Abuse Treat Prev Policy; 2022 Jul; 17(1):56. PubMed ID: 35883186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Motivations for concurrent use of uppers and downers among people who access harm reduction services in British Columbia, Canada: findings from the 2019 Harm Reduction Client Survey.
    Steinberg A; Mehta A; Papamihali K; Lukac CD; Young S; Graham B; Lock K; Fleury M; Buxton JA
    BMJ Open; 2022 May; 12(5):e060447. PubMed ID: 35501101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations with experience of non-fatal opioid overdose in British Columbia, Canada: a repeated cross sectional survey study.
    Ferguson M; Choisil P; Lamb J; Burmeister C; Newman C; Lock K; Tobias S; Liu L; Buxton JA
    Harm Reduct J; 2023 Dec; 20(1):178. PubMed ID: 38093272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High prevalence of non-fatal overdose among people who inject drugs in Malaysia: Correlates of overdose and implications for overdose prevention from a cross-sectional study.
    Bazazi AR; Zelenev A; Fu JJ; Yee I; Kamarulzaman A; Altice FL
    Int J Drug Policy; 2015 Jul; 26(7):675-81. PubMed ID: 25532449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementation of Safe Supply Alternatives During Intersecting COVID-19 and Overdose Health Emergencies in British Columbia, Canada, 2021.
    McNeil R; Fleming T; Mayer S; Barker A; Mansoor M; Betsos A; Austin T; Parusel S; Ivsins A; Boyd J
    Am J Public Health; 2022 Apr; 112(S2):S151-S158. PubMed ID: 35262376
    [No Abstract]   [Full Text] [Related]  

  • 28. Concurrent use of opioids and stimulants and risk of fatal overdose: A cohort study.
    Palis H; Xavier C; Dobrer S; Desai R; Sedgemore KO; Scow M; Lock K; Gan W; Slaunwhite A
    BMC Public Health; 2022 Nov; 22(1):2084. PubMed ID: 36380298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acceptability of technological solutions for overdose monitoring: Perspectives of people who use drugs.
    Tsang VWL; Papamihali K; Crabtree A; Buxton JA
    Subst Abus; 2021; 42(3):284-293. PubMed ID: 31657675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prescription of High-Dose Opioids Among People Living with HIV in British Columbia, Canada.
    Clark J; Fairbairn N; Nolan S; Li T; Wu A; Barrios R; Montaner J; Ti L;
    AIDS Behav; 2019 Dec; 23(12):3331-3339. PubMed ID: 31286318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns and history of prescription drug use among opioid-related drug overdose cases in British Columbia, Canada, 2015-2016.
    Smolina K; Crabtree A; Chong M; Zhao B; Park M; Mill C; Schütz CG
    Drug Alcohol Depend; 2019 Jan; 194():151-158. PubMed ID: 30439611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The implementation and role of a staff naloxone program for non-profit community-based sites in British Columbia: A descriptive study.
    Williams S; King T; Papamihali K; Buxton JA
    PLoS One; 2021; 16(5):e0251112. PubMed ID: 33983996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Negative changes in illicit drug supply during COVID-19: Associations with use of overdose prevention and health services among women sex workers who use drugs (2020-2021).
    Moreheart S; Shannon K; Krüsi A; McDermid J; Ettinger E; Braschel M; Goldenberg SM
    Int J Drug Policy; 2023 Nov; 121():104212. PubMed ID: 37797570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Personal experience and awareness of opioid overdose occurrence among peers and willingness to administer naloxone in South Africa: findings from a three-city pilot survey of homeless people who use drugs.
    Wilson M; Brumwell A; Stowe MJ; Shelly S; Scheibe A
    Harm Reduct J; 2022 Feb; 19(1):17. PubMed ID: 35148779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal methamphetamine use in British Columbia, Canada: A cross-sectional study of people who access harm reduction services.
    Papamihali K; Collins D; Karamouzian M; Purssell R; Graham B; Buxton J
    PLoS One; 2021; 16(5):e0252090. PubMed ID: 34038452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Social network support and harm reduction activities in a peer researcher-led pilot study, British Columbia, Canada.
    Elkhalifa S; Jozaghi E; Marsh S; Thomson E; Gregg D; Buxton J; Jolly A
    Harm Reduct J; 2020 Aug; 17(1):57. PubMed ID: 32825836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlates of seeking emergency medical help in the event of an overdose in British Columbia, Canada: Findings from the Take Home Naloxone program.
    Karamouzian M; Kuo M; Crabtree A; Buxton JA
    Int J Drug Policy; 2019 Sep; 71():157-163. PubMed ID: 30691944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent changes in trends of opioid overdose deaths in North America.
    Imtiaz S; Shield KD; Fischer B; Elton-Marshall T; Sornpaisarn B; Probst C; Rehm J
    Subst Abuse Treat Prev Policy; 2020 Aug; 15(1):66. PubMed ID: 32867799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Take-home drug checking as a novel harm reduction strategy in British Columbia, Canada.
    Klaire S; Janssen RM; Olson K; Bridgeman J; Korol EE; Chu T; Ghafari C; Sabeti S; Buxton JA; Lysyshyn M
    Int J Drug Policy; 2022 Aug; 106():103741. PubMed ID: 35671687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-related harm coinciding with income assistance payments: results from a community-based cohort of people who use drugs.
    Richardson L; Dong H; Kerr T; Milloy MJ; Hayashi K
    Addiction; 2021 Mar; 116(3):536-545. PubMed ID: 32621376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.